INS and type 2 diabetes mellitus: Also, in DIO/MetS/T2DM, we presently do not know if β‐cell aPKC activity is altered downward (as in muscle—see below), or upward (as in liver), in which case, it may participate in mediating compensatory increases in insulin secretion.